Compass Pathways reports positive second Phase 3 trial for COMP360 in treatment-resistant depression
Compass Pathways has reported that its second pivotal Phase 3 [...]
Speaking at Baltic Life Sciences, Laura Korsakova, co-founder and CEO [...]
Compass Pathways has reported that its second pivotal Phase 3 [...]
Speaking at Baltic Life Sciences, Laura Korsakova, co-founder and CEO [...]